Baird analyst Matthew Gillmor reiterated an Outperform rating and $25.00 price target on Evolent Health (NYSE: EVH) and added the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE